Records containing: Parkinson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-01-31Effect of Dual-Task Interference on Upper Extremity Motor Experience With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-29Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject
-
CLINICAL_TRIALS study record update · 2025-01-29Evaluation of Dysphagia in Patients Diagnosed With Parkinson's Disease by Ultrasound: A Controlled Study
-
CLINICAL_TRIALS study record update · 2025-01-29Possibilities of Use Magnetic Resonance Imaging (MRI)-Guided Laser Interstitial Thermal Therapy (LITT) in Treatment of Medically Intractable Tremor
-
CLINICAL_TRIALS study record update · 2025-01-28Investigation of Validity and Reliability of the Minnesota Manual Dexterity Test in Patients with Parkinson's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-01-27A Randomised, Placebo-controlled, Multicentre Phase IIb Study Evaluating the Efficacy of Pirepemat on Falls Frequency in Patients with Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-24Effect of Biological Sex on Multimodal Biomarkers of Disease Progression in Patients with Parkinson's Disease: from Pathophysiological Mechanisms to Equitable Health Outcomes
-
CLINICAL_TRIALS study record update · 2025-01-23Effect of the SpiroGym App on Voluntary Cough Strength in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-23Predicting Motor Learning of an Upper Limb Task Based on Behavioral and Disease-specific Characteristics in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-23Etude Des Facteurs Prédictifs De L'apparition Et De L'évolution De La Maladie De Parkinson
-
CLINICAL_TRIALS study record update · 2025-01-23Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
-
CLINICAL_TRIALS study record update · 2025-01-17Can Task Specificity and Baseline Outcomes Impact TDCS-linked Motor and Cognitive Training Gains in Parkinson's Disease? a Protocol for a Controlled, Double-blind, Randomized Multicentric Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-01-14Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE): A Project of MRI-informed Computational Head Model
-
CLINICAL_TRIALS study record update · 2025-01-14Development of a Multifunctional Rehabilitation Standing and Stepping Device for Persons With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-14Comparative Effects of Alexander Techniques and Feldenkrais Method on Balance, Fear of Fall and Quality of Life in Patients With Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2025-01-13Cohort of the French Clinical Research Network for Parkinson's Disease (NS-PARK Cohort)
-
CLINICAL_TRIALS study record update · 2025-01-09Sing for Your Saunter: Using Self-generated Rhythmic Cues to Enhance Gait in Parkinson's - Dementia Supplement
-
CLINICAL_TRIALS study record update · 2025-01-07A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease (SEASEiPPD)
-
CLINICAL_TRIALS study record update · 2025-01-07Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-07Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-01-01Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2025-01-01Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study
-
CLINICAL_TRIALS study record update · 2024-12-30Balance Confidence, Kinesiophobia, and Associated Factors in Parkinson's Disease: A Controlled Study
-
CLINICAL_TRIALS study record update · 2024-12-20Does Pimavanserin (Nuplazid) Improve Sleep in Patients With Parkinson Disease Psychosis? A Pilot Study
-
CLINICAL_TRIALS study record update · 2024-12-20Magnetic Seizure Therapy for Parkinson's Disease